Register for AllyCon 2024
Join us for a supportive, empowering, and uplifting three-day experience, where colorectal cancer patients, caregivers, and advocates unite against colorectal cancer. Register by October 14 for early bird pricing.
If you or a loved one has just been diagnosed with colorectal cancer, it's important to find out as much as you can about the disease. Visit our newly diagnosed page to find helpful information and resources to put you on the path to survivorship.
No matter how you've been impacted by colorectal cancer, we're here for you with information and support about treatment.
Colorectal cancer is highly treatable, but going through treatment can be tough. Knowing what to expect can help. We've put together helpful information and resources about your treatment options.
Now that you've defeated colorectal cancer, what comes next? Get information and resources about being a colorectal cancer survivor, from monitoring for recurrence to staying cancer-free.
When a loved one is diagnosed with cancer, you’re shoved into a world of medical appointments and barely understandable cancer jargon. We've assembled a collection of caregiver resources to help.
There are several treatment options for colorectal cancer. We're here to help you learn more about each treatment option and what to expect.
Surgery for colorectal cancer is when a surgeon removes the diseased portion of your colon and/or rectum.
A colostomy is created when a portion of the colon or the rectum is removed and the remaining colon is brought to the abdominal wall.
Colorectal cancer can also be treated using systemic therapies like chemo and radiation that reach cancer cells throughout the body.
Clinical trials are an important treatment option to consider. Answer a simple series of questions about your medical condition to find relevant trials that may fit your needs.
Understanding your biomarkers helps you and your doctor decide on the most effective treatment plan for your colon cancer. During biomarker testing, doctors collect a sample of your tumor or your blood to look for unique characteristics, such as whether your cancer is caused by an inherited mutation.
Colon cancer treatment can be challenging for both the body and the mind. Many patients describe difficult emotions such as loneliness, anger, guilt, sadness, and worry, in addition to feeling overwhelmed with uncertainty about their health and other areas of their life.
Kelly Kranson was 39 years old when she was diagnosed with colorectal cancer that had spread to her ovaries. A mom to three young children, Kelly faced tremendous physical and mental challenges – and learned a lot of lessons about facing colon cancer treatment, which she shares in this blog.
When you're undergoing treatment for colorectal cancer, it can be helpful to seek support. Resources, information, and allies to talk to are always available.
BlueHQ is a free, comprehensive support hub that delivers personalized resources, tools, and communities to better navigate colorectal cancer.
The Alliance's certified patient and family support navigation team is here to assist colorectal cancer patients, survivors, and caregivers.
No one should experience colorectal cancer alone. Our national network of survivors and advocates is standing ready to be your ally.
A vetted Buddy who has been through a similar diagnosis can share meaningful and useful advice that helped them get through colorectal cancer.
Our trusted resource library offers articles, videos, guides, and other information to help you and your loved ones navigate colorectal cancer.
The Alliance’s Personalized Treatment Program provides no-cost testing and analysis of your cancer and medical history. The results provide you and your care team with personalized treatment recommendations.
Learn about The Cancer Promise initiative and how political candidates can pledge to support cancer research, prevention, and care policies. Make your voice heard this election.
The treatment option is for patients with KRASG12C-mutated locally advanced or metastatic colorectal cancer (CRC) who have received prior treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.
This bipartisan legislation aims to improve participation in clinical trials by addressing major barriers such as non-medical expenses, trial location accessibility, diverse participation, and financial implications for patients.